Prelude Capital Management, LLC Landec Corp \Ca\ Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
N/A
22,745 New
22,745 $0
Q1 2023

May 15, 2023
BUY
N/A
21,295 New
21,295 $0
Q4 2019

Feb 14, 2020
SELL
$9.09 - $11.89 $14,907 - $19,499
-1,640 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$9.66 - $12.36 $9,186 - $11,754
951 Added 138.03%
1,640 $18,000
Q2 2019

Aug 14, 2019
BUY
$9.32 - $12.98 $6,421 - $8,943
689 New
689 $6,000

Others Institutions Holding LNDC

# of Institutions
76
Shares Held
20.3M
Call Options Held
79.7K
Put Options Held
31.6K
View Full List

About LANDEC CORP \CA\

LNDC Quotes by TradingView
  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email